Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Caplin Steriles is an India-based sterile pharmaceuticals company focused on the development, manufacture, and commercialization of injectable and ophthalmic generic products for regulated markets, especially the United States. The company is a subsidiary of Caplin Point Laboratories and operates as a specialized sterile-products arm with capabilities spanning R&D, regulatory filings, manufacturing, and partner-supported commercialization. Its portfolio includes simple and complex injectables, infusion bags, suspensions, emulsions, lyophilized products, and ophthalmic formulations, and it has built a substantial U.S. ANDA pipeline with numerous FDA approvals. Caplin Steriles also supports external partners on a CDMO basis and has front-end U.S. commercial operations through Caplin Steriles USA. The business is centered on commercial-stage generic products rather than novel therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Caplin Steriles.